Keywords: orphan, status, csl, behring, riastap, been, informed

Orphan status for CSL Behring's RiaSTAP

Article | 16 March 2009

Print This

CSL Behring has been informed by the US Food and Drug Administration that because RiaSTAP is the first FDA-approved treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in